Raymond James Financial Services Advisors, Inc. G1 Therapeutics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$2.2 - $4.98 $12,267 - $27,768	5,576 Added 17.75%	36,987 $84,000
Q1 2024 Apr 22, 2024	SELL	$2.1 - $4.83 $4,846 - $11,147	-2,308 Reduced 6.84%	31,411 $135,000
Q4 2023 Jan 16, 2024	SELL	$1.12 - $3.73 $10,894 - $36,281	-9,727 Reduced 22.39%	33,719 $102,000
Q3 2023 Oct 24, 2023	BUY	$1.22 - $2.67 $5,669 - $12,407	4,647 Added 11.98%	43,446 $62,000
Q2 2023 Jul 25, 2023	SELL	$2.46 - $3.14 $3,999 - $5,105	-1,626 Reduced 4.02%	38,799 $96,000
Q1 2023 Apr 14, 2023	SELL	$2.57 - $8.16 $9,568 - $30,379	-3,723 Reduced 8.43%	40,425 $108,000
Q4 2022 Feb 08, 2023	SELL	$5.19 - $13.5 $40,663 - $105,772	-7,835 Reduced 15.07%	44,148 $239,000
Q3 2022 Oct 25, 2022	BUY	$5.17 - $16.99 $620 - $2,038	120 Added 0.23%	51,983 $649,000
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $7,118 - $14,994	-1,762 Reduced 3.29%	51,863 $256,000
Q1 2022 May 11, 2022	BUY	$7.6 - $11.02 $25,710 - $37,280	3,383 Added 6.73%	53,625 $408,000
Q4 2021 Feb 08, 2022	BUY	$10.16 - $16.17 $90,921 - $144,705	8,949 Added 21.67%	50,242 $513,000
Q3 2021 Nov 02, 2021	BUY	$13.16 - $22.47 $14,120 - $24,110	1,073 Added 2.67%	41,293 $554,000
Q2 2021 Aug 11, 2021	SELL	$19.57 - $26.32 $7,417 - $9,975	-379 Reduced 0.93%	40,220 $882,000
Q1 2021 May 14, 2021	BUY	$17.58 - $32.59 $19,091 - $35,392	1,086 Added 2.75%	40,599 $977,000
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $133,055 - $246,982	-12,107 Reduced 23.45%	39,513 $711,000
Q3 2020 Nov 04, 2020	BUY	$11.55 - $23.75 $179,001 - $368,077	15,498 Added 42.9%	51,620 $596,000
Q2 2020 Jul 17, 2020	BUY	$9.57 - $24.37 $345,687 - $880,293	36,122 New	36,122 $876,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account